


Keranova’s FemtoMatrix technology produces unprecedented results in clinical regulatory trials

Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent

Electroducer announces the publication of positive results from its pilot study in EuroIntervention medical journal

PDC*line Pharma presents first immunological results from phase I/II trial with PDC*lung01 at ESMO-IO 2022

Positive results from AELIX’ HIV therapeutic vaccine clinical study published in Nature Medicine

ABL and Imugene partner to advance oncolytic virus candidate towards later phase clinical trials

admed laboratory adopts QuantaMatrix dRAST solution in routine clinical use

Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532
